OA & HA Facts
These produce Hyaluronic Acid.
What are synoviocytes?
This product is FDA approved as a series of 3 OR 4 injections.
What is ORTHOVISC?
This product has the J-Code J7328.
What is GELSYN-3?
This product has the J-Code J7318.
What is DUROLANE?
This Massachusetts location is home to our DePuy Synthes campus that you will visit later this month.
Where is Raynham?
Synovial inflammation is present in this percentage of OA patients.
What is 70-90%?
This product has the highest HA content of all the single injections on the market.
What is MONOVISC?
This Avian-derrived injection is distributed by Fidia.
What is HYALGAN?
This Avain-derrived product is distributed by Sanofi Aventis.
What is SYNVISC-ONE?
On Monday's first session, we heard from this Kentucky-based EI leader.
Who is Jason McGlincy?
Greater concentrations of HA and higher molecular weights can contribute to this.
This product has the J-Code J7324.
What is ORTHOVISC?
This injection is non-Avian and is manufactured by Ferring.
What is EUFLEXXA?
This is the only non-Avain single injection besides MONOVISC.
What is DUROLANE?
On Monday, Chris Hadley presented on this comprehensive sales training program.
What is Integrity Selling?
This process is used to increase the molecular weight of HA.
What is crosslinking?
This product has the J-Code J7327.
What is MONOVISC?
These two multi-injections marketed by Bioventus.
What are GELSYN-3 and SUPARTZ FX?
This single injection has the same Hyaluronic Acid content as one Orthovisc injection.
What is GEL-ONE?
On Wednesday, we heard from this director of market access.
Who is Bryan Pemberton?
Key attributes of hyaluronic acid that influence rheologic properties.
What are concentration, molecular weight, HA chain interactions?
The difference in pain relief at 8 weeks when comparing 4 OV injections vs. 3 OV injections.
What is a 10% increase?
These two multi-injections have the J-Code J7321.
What are HYALGAN and SUPARTZ FX?
This single injection is comprised of 3-series multi-injection put into one syringe.
What is SYNVISC-ONE?
This J&J pharmaceutical division is headquartered in Belgium.